Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Are we HER-ting for innovation in neoadjuvant breast cancer trial design?

    Snoj N, Bedard PL, de Azambuja E, Cardoso F, Piccart M.

    Breast Cancer Res. 2009;11(1):201. Epub 2009 Jan 16. Review.

    PMID:
    19216727
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    A clinical development paradigm for cancer vaccines and related biologics.

    Hoos A, Parmiani G, Hege K, Sznol M, Loibner H, Eggermont A, Urba W, Blumenstein B, Sacks N, Keilholz U, Nichol G; Cancer Vaccine Clinical Trial Working Group.

    J Immunother. 2007 Jan;30(1):1-15. Review.

    PMID:
    17198079
    [PubMed - indexed for MEDLINE]
    3.

    Research issues affecting preoperative systemic therapy for operable breast cancer.

    Wolff AC, Berry D, Carey LA, Colleoni M, Dowsett M, Ellis M, Garber JE, Mankoff D, Paik S, Pusztai L, Smith ML, Zujewski J.

    J Clin Oncol. 2008 Feb 10;26(5):806-13. Review.

    PMID:
    18258990
    [PubMed - indexed for MEDLINE]
    4.

    I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy.

    Barker AD, Sigman CC, Kelloff GJ, Hylton NM, Berry DA, Esserman LJ.

    Clin Pharmacol Ther. 2009 Jul;86(1):97-100. Epub 2009 May 13.

    PMID:
    19440188
    [PubMed - indexed for MEDLINE]
    5.

    Challenges in breast cancer clinical trial design in the postgenomic era.

    Loi S, Buyse M, Sotiriou C, Cardoso F.

    Curr Opin Oncol. 2004 Nov;16(6):536-41. Review.

    PMID:
    15627014
    [PubMed - indexed for MEDLINE]
    6.

    Neoadjuvant therapy for breast cancer: assessing treatment progress and managing poor responders.

    Wesolowski R, Budd GT.

    Curr Oncol Rep. 2009 Jan;11(1):37-44. Review.

    PMID:
    19080740
    [PubMed - indexed for MEDLINE]
    7.

    Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

    Shimizu C, Masuda N, Yoshimura K, Tsuda H, Mano M, Ando M, Tamura K, Fujiwara Y.

    Jpn J Clin Oncol. 2009 Aug;39(8):484-90. Epub 2009 May 28.

    PMID:
    19477897
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Enhancing the efficacy of hormonal agents with selected targeted agents.

    Johnston SR.

    Clin Breast Cancer. 2009 Jun;9 Suppl 1:S28-36. Review.

    PMID:
    19561004
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Neoadjuvant endocrine therapy models.

    Murray J, Miller WR, Dixon JM.

    Methods Mol Med. 2006;120:489-502.

    PMID:
    16491621
    [PubMed - indexed for MEDLINE]
    10.

    Development of pharmacogenomic markers to select preoperative chemotherapy for breast cancer.

    Pusztai L, Symmans FW, Hortobagyi GN.

    Breast Cancer. 2005;12(2):73-85. Review.

    PMID:
    15858436
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Chemotherapy: Neoadjuvant trial design: time for a brave new world?

    McArthur HL, Hudis CA.

    Nat Rev Clin Oncol. 2010 Jul;7(7):359-60. No abstract available.

    PMID:
    20592708
    [PubMed - indexed for MEDLINE]
    12.

    Predicting endocrine therapy responsiveness in breast cancer.

    Ma CX, Sanchez CG, Ellis MJ.

    Oncology (Williston Park). 2009 Feb;23(2):133-42. Review.

    PMID:
    19323294
    [PubMed - indexed for MEDLINE]
    13.

    Translational research in breast cancer.

    Toi M, Takebayashi Y, Chow LW.

    Breast Cancer. 2005;12(2):86-90. Review.

    PMID:
    15858437
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    Beyond trastuzumab: overcoming resistance to targeted HER-2 therapy in breast cancer.

    Bedard PL, de Azambuja E, Cardoso F.

    Curr Cancer Drug Targets. 2009 Mar;9(2):148-62. Review.

    PMID:
    19275756
    [PubMed - indexed for MEDLINE]
    15.

    Potential modern alternative designs for caries clinical trials (CCTs) and how these can be validated against the conventional model.

    Chesters RK, Ellwood RP, Biesbrock AR, Smith SR.

    J Dent Res. 2004;83 Spec No C:C122-4.

    PMID:
    15286138
    [PubMed - indexed for MEDLINE]
    16.

    Designing the future shape of breast cancer diagnosis, prognosis and treatment.

    Dowsett M.

    Breast Cancer Res Treat. 2004;87 Suppl 1:S27-9.

    PMID:
    15597218
    [PubMed - indexed for MEDLINE]
    17.

    Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.

    Wang S, Yang H, Tong F, Zhang J, Yang D, Liu H, Cao Y, Liu P, Zhou P, Cheng L, Liu M, Guo J.

    Gan To Kagaku Ryoho. 2009 Feb;36(2):255-8.

    PMID:
    19223741
    [PubMed - indexed for MEDLINE]
    18.

    Clinical implementation of soluble EGFR (sEGFR) as a theragnostic serum biomarker of breast, lung and ovarian cancer.

    Baron AT, Wilken JA, Haggstrom DE, Goodrich ST, Maihle NJ.

    IDrugs. 2009 May;12(5):302-8. Review.

    PMID:
    19431095
    [PubMed - indexed for MEDLINE]
    19.

    The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studies.

    Gelenberg AJ, Thase ME, Meyer RE, Goodwin FK, Katz MM, Kraemer HC, Potter WZ, Shelton RC, Fava M, Khan A, Trivedi MH, Ninan PT, Mann JJ, Bergeson S, Endicott J, Kocsis JH, Leon AC, Manji HK, Rosenbaum JF.

    J Clin Psychiatry. 2008 Oct;69(10):1513-28. Epub 2008 Oct 7. Erratum in: J Clin Psychiatry. 2008 Dec;69(12):1985.

    PMID:
    19192434
    [PubMed - indexed for MEDLINE]
    20.

    Neoadjuvant bevacizumab, docetaxel and capecitabine combination therapy for HER2/neu-negative invasive breast cancer: Efficacy and safety in a phase II pilot study.

    Greil R, Moik M, Reitsamer R, Ressler S, Stoll M, Namberger K, Menzel C, Mlineritsch B.

    Eur J Surg Oncol. 2009 Oct;35(10):1048-54. Epub 2009 Feb 27.

    PMID:
    19250795
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk